Showing 1481-1490 of 18587 results for "".
Unpacking Post-COVID Cognitive Changes: The Potential Role of Immune Exhaustion
https://reachmd.com/programs/clinicians-roundtable/unpacking-post-covid-cognitive-changes-the-potential-role-of-immune-exhaustion/35466/A recent prospective study evaluated long-term cognitive outcomes in post-COVID patients using advanced imaging, biomarker analysis, and specialist assessments. It revealed a pattern suggestive of immune exhaustion, including elevated markers tied to wound healing and blood-brain barrier integrity aEmerging Biomarkers for Remyelination in MS: From Fluid Markers to Imaging
https://reachmd.com/programs/neurofrontiers/emerging-biomarkers-for-remyelination-in-ms-from-fluid-markers-to-imaging/32801/As multiple sclerosis (MS) research shifts towards neuroprotection and restoration of function, our toolkit of biomarkers to help detect and monitor remyelination is constantly evolving. Join Dr. Ahmed Abdelhak as he discusses recent advancements in body fluid markers and imaging techniques, which hLooking Beyond the Skin: The Far-Reaching Impacts of Psoriasis
https://reachmd.com/programs/frontlines-psoriasis/looking-beyond-the-skin-the-far-reaching-impacts-of-psoriasis/32436/Discover how the impacts of psoriasis extend beyond the skin, affecting quality of life, musculoskeletal health, and overall well-being.Inflammatory Gateways: Exploring the Role of the Choroid Plexus in Post-TBI Care
https://reachmd.com/programs/neurofrontiers/inflammatory-gateways-exploring-the-role-of-the-choroid-plexus-in-post-tbi-care/32868/Traumatic brain injuries (TBIs) trigger a rapid transcriptional response in the choroid plexus, dominated by chemokines that attract neutrophils. Join Dr. Prajwal Ciryam, Assistant Professor of Neurology at the University of Maryland School of Medicine, as he explains how this early signaling may reMelanoma Treatment Breakthroughs: Improving Long-Term Survival
https://reachmd.com/programs/medical-industry-feature/melanoma-treatment-breakthroughs-improving-long-term-survival/32930/Explore how early immunotherapy and emerging treatments are reshaping survival rates for patients with melanoma.FcRn Inhibitors: A Potential New Targeted Therapy Option
https://reachmd.com/programs/neurofrontiers/tbd/30071/Here’s how FcRn inhibitors can offer a new approach to generalized myasthenia gravis treatment.Insights on the Rising Rates of Syphilis in the United States
https://reachmd.com/programs/clinicians-roundtable/insights-on-the-rising-rates-of-syphilis-in-the-united-states/24153/The United States has seen a 200% increase in congenital syphilis cases in the past five years. Here’s why.Improving Outcomes of HIV Among the Latino Population
https://reachmd.com/programs/clinicians-roundtable/improving-outcomes-of-hiv-among-the-latino-population/15747/What strategies will help decrease the rates of HIV infections within the Latino community? Dive in.Bringing Injectable Treatment to HIV Patients in Atlanta
https://reachmd.com/programs/clinicians-roundtable/bringing-injectable-treatment-to-hiv-patients-in-atlanta/15829/From using tablets for PrEP to incorporating an injectable therapy for HIV patients, learn how the PrEP program is helping medication access in Atlanta, Georgia.An Overview of Guideline Updates for IBS-C
https://reachmd.com/programs/gi-insights/an-overview-of-guideline-updates-for-ibs-c/14616/What do the new guidelines recommend for the treatment of irritable bowel syndrome with constipation?